AWM
BSX icon

Apollon Wealth Management’s Boston Scientific BSX Stock Holding History

Apollon Wealth Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.38M Buy
32,281
+7,234
+29% +$393K 0.02% 615
2026
Q1 		$1.57M Buy
25,047
+460
+2% +$36.8K 0.03% 443
2025
Q4 		$2.34M Sell
24,587
-585
-2% -$57.4K 0.04% 341
2025
Q3 		$2.46M Buy
25,172
+346
+1% +$35.8K 0.04% 341
2025
Q2 		$2.67M Buy
24,826
+1,929
+8% +$195K 0.05% 294
2025
Q1 		$2.31M Buy
22,897
+2,542
+12% +$256K 0.05% 296
2024
Q4 		$1.82M Buy
20,355
+1,793
+10% +$158K 0.04% 358
2024
Q3 		$1.56M Sell
18,562
-394
-2% -$31.1K 0.04% 364
2024
Q2 		$1.46M Sell
18,956
-2,364
-11% -$173K 0.04% 360
2024
Q1 		$1.46M Buy
21,320
+597
+3% +$38.4K 0.05% 355
2023
Q4 		$1.2M Buy
20,723
+9,111
+78% +$486K 0.04% 396
2023
Q3 		$613K Sell
11,612
-1,361
-10% -$71.4K 0.03% 494
2023
Q2 		$702K Sell
12,973
-4,797
-27% -$251K 0.03% 507
2023
Q1 		$889K Buy
17,770
+1,821
+11% +$85.8K 0.05% 364
2022
Q4 		$738K Sell
15,949
-1,025
-6% -$44.4K 0.05% 388
2022
Q3 		$657K Sell
16,974
-2
-0% -$80 0.05% 372
2022
Q2 		$633K Sell
16,976
-1,308
-7% -$53.2K 0.05% 373
2022
Q1 		$810K Sell
18,284
-2,275
-11% -$98.6K 0.06% 339
2021
Q4 		$873K Buy
20,559
+8,747
+74% +$368K 0.07% 313
2021
Q3 		$513K Buy
+11,812
New +$523K 0.07% 262
2020
Q3 		– Sell
-635
Closed -$22K – 221
2020
Q2 		$22K Buy
+635
New +$22.9K 0.01% 353

Other funds holding BSX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return
BPCE
Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return

Apollon Wealth Management's BSX Position: Q2 2026 in Review

Apollon Wealth Management increased its Boston Scientific (BSX) stake by 29% in Q2 2026, buying an estimated $393K and bringing the position to 32,281 shares worth $1.38M. The position accounts for 0.02% of the portfolio, ranked #615.

Apollon Wealth Management first reported a position in BSX in Q2 2020 and has held it in 21 quarters since. The position peaked at $2.67M in Q2 2025. 338 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Apollon Wealth Management held 32,281 shares of Boston Scientific worth $1.38M as of Q2 2026.
  • Apollon Wealth Management bought 7,234 Boston Scientific shares in Q2 2026, an estimated $393K.
  • Boston Scientific made up 0.02% of Apollon Wealth Management's portfolio in Q2 2026, its #615 holding.
  • Apollon Wealth Management first reported a position in Boston Scientific in Q2 2020 and has held it in 21 quarters since.
  • Apollon Wealth Management's Boston Scientific position peaked at $2.67M in Q2 2025.
  • 338 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Apollon Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.